Senior Correspondent SNAP benefits at risk due to the government shutdown, the AG putting Big Tech on trial, and more Length: ...

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...

PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) ...

DUBLIN, Oct. 09, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment ...

RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, ...

We invite researchers to submit abstracts for oral presentations in the field of medicinal chemistry, focusing on the latest innovations in drug design, discovery, and development. Topics of… Read ...

Acceptance for a poster presentation at the SITC Annual Meeting underscores the scientific rigor and innovation behind HCB301's development. SITC is the world's largest annual conference solely ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. UPDATE: Oct. 6, 6:00 p.m.

ROCKVILLE, Md., Oct. 20, 2025 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta” or the “Company”), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative ...